LEVIM BIOTECH LLP
Founded in 2014
About LEVIM BIOTECH LLP
Levim Biotech LLP is a leading bio-pharmaceutical firm specializing in the development and commercialization of bio-pharmaceuticals for acute diseases, oncology, and metabolic disorders. Their portfolio includes peptides, proteins, antibody fragments, gene therapy products, and novel drug delivery technologies. They are committed to addressing healthcare requirements in the field of human therapeutics and diagnostics, utilizing advanced technologies such as recombinant technology and macro-molecule conjugation.
Public Links of LEVIM BIOTECH LLP
Frequently Asked Questions (FAQ)
When was LEVIM BIOTECH LLP founded?
LEVIM BIOTECH LLP was founded in the year 2014.
Who are the founders of LEVIM BIOTECH LLP?
LEVIM BIOTECH LLP is founded by Vimalkumar Jatin and Vimalkumar Nitinkumar.
What are the focus areas of LEVIM BIOTECH LLP?
Who are LEVIM BIOTECH LLP's competitors?
Possible competitors of LEVIM BIOTECH LLP may include Bhamis Research Laboratory, Bioagile Therapeutics Private Limited, Exocan Healthcare Technologies and 7 others.
Get Access to Complete Information
Signup NowYNOS is not associated with any of the entities (organisations / people) mentioned in this page. Information provided here has been curated from multiple public as well as proprietary sources. All efforts have been taken to make it accurate and complete. If details are insufficient or not accurate, kindly suggest edits
Get more information with Debt Funding
Discover Top Loan & Debt Funding Schemes for Startups in India.
Get more information with Insight
The most powerful dashboard solution on Indian Startups & Investors.
Try StartupGPT, an AI-Assistant for Founders & Investors
Your conversational companion for Indian Startups, Funding, and much more.
Get more information with Incubators
The Ultimate Platform for Finding the Right Incubator and Accelerator.
Get more information with Govt. Funding
Discover & analyse the best government funding avenues for your startup in India.
- slide 1 of 8, currently active
- slide 2 of 8
- slide 3 of 8
- slide 4 of 8
- slide 5 of 8
- slide 6 of 8
- slide 7 of 8
- slide 8 of 8
